Business & Regulation

Moderna’s new CFO lasts one day in the job as investigation comes to light.

Celebrate the people, companies, and innovations had the biggest impact on pharma in the last year.

Ukrainian drug discovery has been disrupted by war. We spoke to leaders of its largest player about the domestic industry’s past, present, and future.

The Medicine Maker is proud to present the Power List 2022 and the inaugural Company of the Year Awards

In our second C+G Champions installment, we ask industry leaders in the cell and gene field to answer key questions about the industry.

What do companies need to consider when developing next-gen medicines for rare diseases?

The COVID-19 pandemic exposed weaknesses in pharma supply chains. It’s time to address these.

Medicare publishes policy for amyloid mAbs and Alzheimer’s disease. It’s not good news for Aduhelm.

Get excited, because the results are in! Find out who won the 2022 Innovation Awards

African vaccine production needs a boost. Here’s how Aspen is working to make that happen.